RT Journal Article
SR Electronic
T1 Strategic release of lockdowns in a COVID infection model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.10.20096446
DO 10.1101/2020.05.10.20096446
A1 Yi Zhang
A1 Mohit Hota
A1 Sanjiv Kapoor
YR 2020
UL http://medrxiv.org/content/early/2020/05/15/2020.05.10.20096446.abstract
AB The COVID-19 Pandemic has impacted the world’s socio-economic system, resulting in a serious health crisis and lockdowns around the world. As the growth of infection slows, decisions regarding easing of lockdown restrictions are required, keeping in view the capacity of the health-care system. In this paper, we quantify the impact of a multi-phased release of the population from lockdown. Using the SIR model for epidemic spread, we design and implement a method to determine the earliest time of release from lockdown restrictions, constrained by a specified threshold on the subsequent peaks of infection. Trade-offs between the threshold and the earliest times of removing lockdown restrictions are illustrated. Additionally, we consider alternative policy decisions where the population is released gradually from lockdown restrictions and illustrate the trade-offs between the rate of release of population and number of active infections.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPartially supported by NSF grant No. 2028274Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used is publicly available and referenced. Algorithms and implementations are available from the authors by e-mail request.